A multicentre, randomized trial on the benefit/risk profile of amiodarone, flecainide and propafenone in patients with cardiac disease and complex ventricular arrhythmias. Antiarrhythmic Drug Evaluation Group (A.D.E.G.).

Source:http://linkedlifedata.com/resource/pubmed/id/1396837

Download in:

View as

General Info

PMID
1396837